ENZN has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
ENZN has been removed from your Stock Email Alerts list.
|
Ticker![]() | Date
|
Action |
Impact
![]() |
Price Range (Average)*
![]() |
Current Price | Change from Average![]() |
Comment | Current Shares | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ENZN | 2011-03-31 | Add | 0.16% | $10.14 - $12.48 ($11.15) | $ 1.7 | -85% | Add 16.65% | 700,000 | ||
| ENZN | 2010-03-31 | Add | 0.64% | $9 - $11.28 ($9.99) | $ 1.7 | -83% | Add 137.9% | 530,000 | ||
| ENZN | 2009-09-30 | Add | 0.22% | $7.17 - $8.66 ($7.9) | $ 1.7 | -78% | Add 59.89% | 240,000 | ||
| ENZN | 2009-06-30 | Buy | 0.42% | $5.53 - $8.15 ($6.75) | $ 1.7 | -75% | New holding, 150100 sh. | 150,100 | ||
| | ||||||||||
| Ticker | Guru Name | Portfolio Date* | Current Shares | % of Shares Outstanding | % of Total Assets Managed | Change from Last Holdings | Holding History |
|---|---|---|---|---|---|---|---|
| ENZN | Charles Brandes | 2013-03-31 | 360,865 | 0.83 | 0.02 | +432.17% | |
| ENZN | Michael Price | 2013-03-31 | 748,800 | 1.71 | 0.37 | ||
| ENZN | Carl Icahn | 2013-03-31 | 5,904,863 | 13.51 | 0.13 | ||
| ENZN | Seth Klarman | 2013-03-31 | 7,691,453 | 17.6 | 0.94 | -2.02% |
Most recent portfolio changes are included for Premium Members only!ENZN: Insider Buys/Sells Click Here for All Insider Trades. |
| Insider | Position | Date | Trades | Shares | Trade Price ($) | Change (%) | Details |
|---|---|---|---|---|---|---|---|
| LEBUHN ROBERT | Director | 2012-08-14 | Sell | 5,820 | $6.58 | -74.16 | view |
| LEBUHN ROBERT | Director | 2012-08-10 | Sell | 1,933 | $6.58 | -74.16 | view |
| HEBARD GEORGE | Interim PEO and Interim COO | 2012-06-20 | Buy | 5,000 | $6.88 | -75.29 | view |
| Rackear Andrew D. | VP and General Counsel | 2012-06-05 | Sell | 1,614 | $6.81 | -75.04 | view |
| Conover Charles | SVP, R&D Program Management | 2012-06-05 | Sell | 25,000 | $6.78 | -74.93 | view |
| Young Richard A | Director | 2012-03-15 | Sell | 2,000 | $6.92 | -75.43 | view |
| Rackear Andrew D. | VP and General Counsel | 2011-11-10 | Sell | 3,766 | $6.68 | -74.55 | view |
| Buchbinder Aby | VP, Clinical Development | 2011-11-08 | Sell | 2,700 | $7.06 | -75.92 | view |
| LEBUHN ROBERT | Director | 2011-06-01 | Sell | 8,702 | $10.57 | -83.92 | view |
| Ogden Mark L | Acting VP of Fin & Prin FO | 2011-02-28 | Buy | 2,000 | $10.65 | -84.04 | view |
Add Notes, Comments or Ask Questions
Comments